Bcl-xL is an anti-apoptotic member of the Bcl-2 family that is abundantly expressed in adult neurons and is overexpressed in a number of human cancers, where Bcl-xL contributes importantly to tumor cell survival. Anti-apoptotic Bcl-2 proteins are thought to inhibit apoptosis by directly or indirectly inhibiting pro-apoptotic Bcl-2 family proteins Bax and Bak. If unleashed, Bax and Bak compromise the integrity of the outer mitochondrial membrane, releasing cytochrome c into the cytoplasm to activate the caspases responsible for apoptotic cell death. However, a growing body of evidence suggests that this model of Bcl-2 family function is incomplete, and that Bcl-2 proteins have important functions in healthy cells, particularly in neurons. Furthermore, these non-canonical functions of Bcl-2 proteins appear to be critical for mitochondrial function and neuronal activity, as well as cell viability. Therefore, contrary to previous opinion that cell death regulators act late in the course of disease, long after neuronal function is impaired, Bcl-xL-mediated functions are likely to be critical for functions that are lost in the earliest phases of neurological dysfunction. However, the functions of Bcl-2 family proteins are only rarely studied in healthy cells. We propose to study the effects of Bcl-xL on mitochondrial functions in neurons using biochemical approaches and microscopy to challenge the current dogma regarding Bcl-2 protein localization and to identify the mitochondrial components relevant to Bcl-xL function (Aim 1). We will also investigate the mechanisms underlying the effects of Bcl-xL or mitochondrial dynamics (fission, fusion and biomass control) and energetics (Aim 2), and will determine the role of Bcl-xL in membrane fusion using cellular and in vitro models (Aim 3).
Contrary to popular models, anti-apoptotic protein Bcl-xL, which is abundantly expressed in adult neurons, appears to have critical functions that are distinct from its ability to inhibit pro-apoptotic Bcl-2 family members during the final minutes of cell life. Therefore, we will delineate the mechanisms that explain how Bcl-xL regulates mitochondrial dynamics and enhances neuronal activity in healthy neurons.
|Teng, Xinchen; Hardwick, J Marie (2013) Quantification of genetically controlled cell death in budding yeast. Methods Mol Biol 1004:161-70|
|Lamb, Heather M; Hardwick, J Marie (2013) Unlatched BAX pairs for death. Cell 152:383-4|
|Aouacheria, Abdel; Rech de Laval, Valentine; Combet, Christophe et al. (2013) Evolution of Bcl-2 homology motifs: homology versus homoplasy. Trends Cell Biol 23:103-11|
|Teng, Xinchen; Dayhoff-Brannigan, Margaret; Cheng, Wen-Chih et al. (2013) Genome-wide consequences of deleting any single gene. Mol Cell 52:485-94|
|McNally, Melanie A; Soane, Lucian; Roelofs, Brian A et al. (2013) The N-terminal helix of Bcl-xL targets mitochondria. Mitochondrion 13:119-24|
|Ofengeim, Dimitry; Chen, Ying-Bei; Miyawaki, Takahiro et al. (2012) N-terminally cleaved Bcl-xL mediates ischemia-induced neuronal death. Nat Neurosci 15:574-80|
|Roelofs, Brian A; Hardwick, J Marie (2011) Flying to a halt: Drosophila Aven arrests the cell cycle. Cell Cycle 10:1350-51|
|Abdelwahid, Eltyeb; Rolland, Stephane; Teng, Xinchen et al. (2011) Mitochondrial involvement in cell death of non-mammalian eukaryotes. Biochim Biophys Acta 1813:597-607|
|Chen, Ying-Bei; Aon, Miguel A; Hsu, Yi-Te et al. (2011) Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential. J Cell Biol 195:263-76|
|Alavian, Kambiz N; Li, Hongmei; Collis, Leon et al. (2011) Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase. Nat Cell Biol 13:1224-33|
Showing the most recent 10 out of 30 publications